Vishuo databases aim at targeted medical treatments
Singapore-based health-care tech firm to take its product beyond hospitals in China, Australia and the US, and finds itself up against bigger players such as Thomson Reuters
Add BT as a preferred source
DeeperDive is a beta AI feature. Refer to full articles for the facts.
Singapore
WHEN conventional treatments such as surgery and chemotherapy failed to work for a lung-cancer patient after three years, he turned to Vishuo Biomedical for a course of treatment targeted at his particular gene profile.
The Singapore-based health-care technology company says that not only did the treatment take effect, the patient was well enough several months later to take a holiday in Tibet, where the high altitude makes thin, lower-oxygen air a norm.
Copyright SPH Media. All rights reserved.
TRENDING NOW
Shelving S$5 billion office redevelopment plan proved ‘wise’ as geopolitical risks mount: OCBC chairman
China pips the US if Asean is forced to choose, but analysts warn against reading it like a sports result
Beijing’s calculated silence on the Iran war
Middle East-linked energy supply shocks put Asean Power Grid back in focus
